As a matter of fact, SMS1 was most frequently down-regulated in vulva (5 out of 5), testis (9 out of 10), and skin (9 out of 10) cancers, including melanoma (6 out of 7) (Figure 1B and Supplementary Table 1). This evidence concerns the gene SGMS1 and melanoma.